Recruiting
Phase 2

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

Sponsor:

St. Jude Children's Research Hospital

Code:

NCT06528691

Conditions

High Grade Glioma

CNS Tumor

Eligibility Criteria

Sex: All

Age: 0 - 3

Healthy Volunteers: Not accepted

Interventions

Entrectinib

Cyclophosphamide

Etoposide

Carboplatin

G-CSF

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information